Fact checked byHeather Biele

Read more

November 11, 2024
2 min read
Save

Obstructive sleep apnea increases risk for dementia in midlife adults, especially women

Fact checked byHeather Biele
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Known/suspected obstructive sleep apnea increased dementia risk for midlife men and women, researchers found.
  • At every age, obstructive sleep apnea was associated with higher dementia risk for women vs. men.
Perspective from Jennifer L. Martin, PhD

Adults aged 50 years and older, particularly women, who experienced obstructive sleep apnea appeared to be at higher risk for dementia, according to a new study published in SLEEP Advances.

“Our findings offer new insight into the role of a treatable sleep disorder on long-term cognitive health at the population level for both women and men,” Tiffany J. Braley, MD, MS, the Holtom-Garrett Family Professor of Neurology and section head for multiple sclerosis at Michigan Medicine, said in related university press release.

Psych1124Braley_Graphic_01
Data were derived from Braley TJ, et al. Sleep Adv. 2024;doi:10.1093/sleepadvances/zpae077.

Approximately 7 million Americans are currently living with dementia, which disproportionately affects women, according to the researchers. Previous studies have explored the relationship between obstructive sleep apnea (OSA) and dementia to identify dementia risk factors before cognitive decline begins. However, the comorbidities and environmental exposures that may create this gender disparity need further investigation, they said.

Further, Braley and colleagues added, population-based data that capture potential undiagnosed OSA cases and include longer follow up and more granular cognitive measures are still needed to understand the relationship between OSA and dementia.

This motivated the researchers to explore gender-specific differences in dementia incidence among midlife and older adults with known or suspected OSA.

Their analysis included 18,815 participants (74% white; 54% women; mean age of women, 61 years; mean age of men, 60 years) aged 50 years and older who were dementia-free at baseline recruited from 2010 to 2020 datasets of the Health and Retirement Study (HRS).

The researchers identified patients with known or suspected OSA via self-reported diagnosis or a positive screen on the STOP-Bang questionnaire, which helps identify OSA using medical history and demographic and sleep data. They found that 48% of participants met criteria for known or suspected OSA, the prevalence of which was more than twice as high in men compared with women (68% vs. 31%).

Also, based on a self-reported diagnosis or an HRS-based objective cognitive functioning algorithm, Braley and colleagues identified a total of 2,233 incident dementia cases (women, 9%; men, 8%).

Next, the researchers analyzed differences in the cumulative incidence of dementia by OSA status using survey-weighted regression models based on pseudo-values to account for covariates such as race/ethnicity, educational attainment and cohabitation status.

In unadjusted sex-stratified analyses, the researchers found that known/suspected OSA was associated with increased cumulative incidence of dementia among women and men aged 60 to 84 years, with higher cumulative incidence among women compared with men at every age.

Braley and colleagues found that, by age 80 years, the cumulative incidence of dementia was 4.7% (CI, 2.8-6.7) greater for women and 2.5% (CI, 0.5-4.5) greater for men with known/suspected OSA compared with women and men without OSA.

The association between known/suspected OSA and age-specific dementia reduced after adjusting for confounding variables but remained significant.

The researchers observed several limitations to this study, including a lack of cognitive data and inability to assess adherence to OSA treatment.

“Sleep apnea increases significantly post-menopause yet remains underdiagnosed,” Galit Levi Dunietz, PhD, MPH, associate professor in the division of sleep medicine at the University of Michigan, said in the release. “We need more epidemiologic studies to better understand how sleep disorders in women impact their cognitive health.”

Reference: